Vetoquinol SA

As of December 31, 2025, Vetoquinol SA carries a market capitalization of 971.82M, placing it among publicly traded companies globally. Its enterprise value stands at 766.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Vetoquinol SA's next confirmed earnings release is scheduled for March 25, 2027.

As of December 31, 2025, Vetoquinol SA has 11.62M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Vetoquinol SA maintains a current ratio of 3.08, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 16, 2026, Vetoquinol SA's stock has gained approximately 1.28% over the past 52 weeks. The 50-day moving average sits at 72.22, while the 200-day moving average is 76.17.

As of December 31, 2025, Vetoquinol SA holds 221.08M in cash and equivalents against 15.29M in total debt, resulting in a net debt position of -219.27M. Total book value stands at 591.37M, with working capital of 309.31M providing operational flexibility.